Federal Register of Legislation - Australian Government

Primary content

Specifications as made
This instrument specifies, for the purposes of paragraph 3(5)(ca) of the Therapeutic Goods Act 1989, advisory statements which are required to be included on the label of over the counter medicines and registered complementary medicines. If such statements are not included on the label of these medicines as required, the presentation of the product may be unacceptable. This instrument also repeals and replaces the Medicines Advisory Statements Specification 2017.
Administered by: Health
Registered 27 Feb 2019
Tabling HistoryDate
Tabled HR02-Apr-2019
Tabled Senate02-Apr-2019
Date of repeal 01 Jan 2022
Repealed by Therapeutic Goods (Medicines Advisory Statements) Specification 2021
Help with file formats Help with file formats
Legislative Instrument
F2019L00213 : Authoritative PDF Document : 1.8MB Primary Document Icon F2019L00213 : ZIP Document : 0.2MB
85 pages

Explanatory Statement
F2019L00213ES : PDF Document : 0.7MB Primary Document Icon F2019L00213ES : ZIP Document : 42KB
9 pages